🛡️ ImmunosuppressantsInjectable
IMULDOSA
ustekinumab-srlf
IL-12 and IL-23 antagonist biosimilar to ustekinumab for moderate to severe plaque psoriasis, active psoriatic arthritis, and Crohn's disease.
Form
Injectable
Uses
2
Side effects
4
Category
Immunosuppressants
01
What is IMULDOSA used for?
- Treatment of moderate to severe plaque psoriasis in adults
- Treatment of active psoriatic arthritis and Crohn's disease
02
ustekinumab-srlf side effects
Common side effects of ustekinumab-srlf include:
Nasopharyngitis
Upper respiratory infections
Headache
Fatigue
CommonModerateLess common
03
ustekinumab-srlf warnings & precautions
- Risk of serious infections; evaluate for tuberculosis before starting
- Risk of malignancy with long-term immunosuppressive therapy
Loading FDA data…
04
Frequently asked questions
05
Related medications
Share
Share this drug info.
Help friends and family understand IMULDOSA in plain language.
Disclaimer: This information is sourced from the FDA openFDA database and is provided for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or pharmacist before starting or changing medication.